MSB 2.17% $1.13 mesoblast limited

Cell Therapy News/Articles, page-8310

  1. 15,487 Posts.
    lightbulb Created with Sketch. 5576
    Yet another opioid settlement in the USA today .... quite a number of huge pharma fines in the last 12 months so I do wonder just how much 'interest' there has been from big pharma in our MPC-06-ID product ?

    Fines like these make a partnership deal with Mesoblast look cheap for CLBP



    McKinsey agrees $573m opioid settlement in US

    Published3 hours ago
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.